Compugen Ltd (CGEN)
1.45
+0.02
(+1.40%)
USD |
NASDAQ |
Nov 21, 16:00
1.45
0.00 (0.00%)
After-Hours: 20:00
Compugen Gross Profit Margin (Quarterly): 78.98% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 78.98% |
June 30, 2024 | 76.84% |
March 31, 2024 | 17.86% |
December 31, 2023 | 94.01% |
September 30, 2023 | |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | 88.67% |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | 97.00% |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | 91.23% |
Date | Value |
---|---|
June 30, 2018 | |
March 31, 2018 | 96.50% |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | 33.96% |
September 30, 2016 | 70.00% |
June 30, 2016 | 82.66% |
March 31, 2016 | 12.90% |
December 31, 2015 | 87.54% |
September 30, 2015 | 12.23% |
June 30, 2015 | 33.63% |
March 31, 2015 | 25.54% |
December 31, 2014 | 84.94% |
September 30, 2014 | 56.87% |
June 30, 2014 | 56.26% |
March 31, 2014 | 64.51% |
December 31, 2013 | 54.37% |
September 30, 2013 | 7.86% |
June 30, 2013 | -281.8% |
March 31, 2013 | 7.41% |
December 31, 2012 | -25.37% |
September 30, 2012 | 69.44% |
June 30, 2012 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
17.86%
Minimum
Mar 2024
97.00%
Maximum
Dec 2020
75.56%
Average
83.82%
Median
Gross Profit Margin (Quarterly) Benchmarks
Pluri Inc | 61.35% |
BioLine Rx Ltd | 83.37% |
XTL Biopharmaceuticals Ltd | -- |
Can Fite Biofarma Ltd | -- |
BiomX Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 2.69% |
Return on Assets | 1.49% |
Return on Invested Capital | 2.69% |
Profit Margin (Quarterly) | 7.45% |
Operating Margin (Quarterly) | 26.24% |
Return on Net Operating Assets | 8.01% |